⌘K

Login Start Free

Home/Filings/4/0001062993-20-004522

4//SEC Filing

Chadha Deepak 4

Accession 0001062993-20-004522

CIK 0000819050other

View on SEC.gov Company Profile

Filed

Sep 15, 8:00 PM ET

Accepted

Sep 16, 4:19 PM ET

Size

5.3 KB

Accession

0001062993-20-004522

Insider Transaction Report

Form 4

Period: 2020-09-15

Brickell Biotech, Inc.BBI

Chief Research & Dev. Officer

Transactions

Award
Stock Option (right to buy)
2020-09-15+400,000→ 400,000 total
Exercise: $0.80Exp: 2030-09-15→ Common Stock (400,000 underlying)

Footnotes (1)

[F1]The stock options will vest 25% on September 15, 2021, and the remainder will vest in equal monthly installments over the following three years.

Documents

1 file

4
form4.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Issuer

Brickell Biotech, Inc.

CIK 0000819050

Entity typeother

Related Parties

1

filerCIK 0001784380

Filing Metadata

Form type: 4
Filed: Sep 15, 8:00 PM ET
Accepted: Sep 16, 4:19 PM ET
Size: 5.3 KB

View on SEC.gov